180 Life Sciences Corp. Analysis
| Analyst Ratings |
|
Average Target Price
|
80.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.11
|
0.00
|
0.11
|
100.00%
|
|
2022-09-30
|
0.20
|
-1.40
|
-1.60
|
-800.00%
|
|
2022-06-30
|
-2.60
|
1.80
|
4.40
|
169.23%
|
|
2022-03-31
|
-2.60
|
1.00
|
3.60
|
138.46%
|
|
2021-12-31
|
-2.60
|
1.00
|
3.60
|
138.46%
|
|
2021-09-30
|
-2.40
|
10.80
|
13.20
|
550.00%
|
|
2021-06-30
|
0.00
|
-0.17
|
0.00
|
0.00%
|
|
2021-03-31
|
0.00
|
-0.75
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
1.40
|
|
2021-12-31
|
10.88
|
|
2020-12-31
|
-1.53
|
|
2019-12-31
|
-0.16
|
|
2018-12-31
|
-410.15
|
|
2017-12-31
|
0.02
|